Interpreting high levels of unfolded Von Willebrand Factor in patients with the antiphospholipid syndrome
IntroductionUnfolded Von Willebrand Factor (VWF) is increased in thrombotic pathologies such as myocardial infarction. Unfolded VWF mediates the binding of platelets without the need for collagen. β2-glycoprotein I (β2-GPI) is a natural inhibitor of the platelet-VWF interaction. The antiphospholipid...
Saved in:
| Main Authors: | Romy de Laat-Kremers, Shengshi Huang, Hugo ten Cate, Marisa Ninivaggi, Bas de Laat, Katrien Devreese |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1514433/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01) -
Challenges and considerations of genetic testing in von Willebrand disease
by: Omid Seidizadeh, et al.
Published: (2025-01-01) -
Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women
by: N. R. Gashimova, et al.
Published: (2023-03-01) -
Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023-03-01) -
Alterations in von Willebrand Factor Levels in Patients with Malaria: A Systematic Review and Meta-Analysis of Disease Severity
by: Suriyan Sukati, et al.
Published: (2025-04-01)